1 |
Park JB (2001) Inhibition of glucose and dehydroascorbic acid uptakes by resveratrol in human transformed myelocytic cells. J Nat Prod 64, 381-384
DOI
|
2 |
Hwang SO and Lee GM (2008) Nutrient deprivation induces autophagy as well as apoptosis in chinese hamster ovary cell culture. Biotechnol Bioeng 99, 678-685
DOI
|
3 |
Hassan M, Watari H, Abualmaaty A, Ohba Y and Sakuragi N (2014) Apoptosis and molecular targeting therapy in cancer. Biomed Res Int 2, 1-23
|
4 |
Chou TC and Talalay P (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22, 27-55
DOI
|
5 |
Bjorklund M, Roos J, Gogvadze V and Shoshan M (2011) Resveratrol induces SIRT1- and energy-stress-independent inhibition of tumor cell regrowth after low-dose platinum treatment. Cancer Chemother Pharmacol 68, 1459-1467
DOI
|
6 |
Desoize B and Madoulet C (2002) Particular aspects of platinum compounds used at present in cancer treatment. Crit Rev Oncol Hematol 42, 317-325
DOI
|
7 |
Todd RC and Lippard SJ (2009) Inhibition of transcription by platinum antitumor compounds. Metallomics 1, 280-291
DOI
|
8 |
Wu YJ, Muldoon LL and Neuwelt EA (2005) The chemoprotective agent N-acetylcysteine blocks cisplatininduced apoptosis through caspase signaling pathway. J Pharmacol Exp Ther 312, 424-431
DOI
|
9 |
Ma L, Li W, Wang R et al (2015) Resveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosis. Int J Oncol 47, 1460-1468
DOI
|
10 |
Wang J, He D, Zhang Q, Han Y, Jin S and Qi F (2009) Resveratrol protects against cisplatin-induced cardiotoxicity by alleviating oxidative damage. Cancer Biother Radiopharm 24, 675-680
DOI
|
11 |
Simsek G, Tokgoz S, Vuralkan E, Caliskan M, Besalti O and Akin I (2013) Protective effects of resveratrol on cisplatin-dependent inner-ear damage in rats. Eur Arch Otorhinolaryngol 270, 1789-1793
DOI
|
12 |
Kim D, Jung Y, Lee J et al (2011) SIRT1 activation by resveratrol ameliorates cisplatin-induced renal injury through deacetylation of p53. Am J Physiol Renal Physiol 301, F427-F435
DOI
|
13 |
De Oliveira MR, Nabavi SF, Manayi A, Daglia M, Hajheydari Z and Nabavi SM (2016) Resveratrol and the mitochondria: from triggering the intrinsic apoptotic pathway to inducing mitochondrial biogenesis, a mechanistic view. Biochim Biophys Acta 1860, 727-745
DOI
|
14 |
Huang Y, Anderle P, Bussey KJ et al (2004) Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res 64, 4294-4301
DOI
|
15 |
Wise DR and Thompson CB (2010) Glutamine addiction: a new therapeutic target in cancer. Trends BiochemSci 35, 427-433
DOI
|
16 |
Bode BP, Fuchs BC, Hurley BP et al (2002) Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. Am J Physiol Gastrointest Liver Physiol 283, G1062-1073
DOI
|
17 |
Wang Q, Beaumont KA, Otte NJ et al (2014) Targeting glutamine transport to suppress melanoma cell growth. Int J Cancer 135, 1060-1071
DOI
|
18 |
Willems L, Jacque N, Jacquel A et al (2013) Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. Blood 122, 3521-3532
DOI
|
19 |
Hassanein M, Hoeksema MD, Shiota M et al (2013) SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin Cancer Res 19, 560-570
DOI
|
20 |
Ren P, Yue M, Xiao D et al (2015) ATF4 and N-Myc coordinate glutamine metabolism in MYCN-amplified neuroblastoma cells through ASCT2 activation. J Pathol 235, 90-100
DOI
|
21 |
Kaira K, Sunose Y, Arakawa K et al (2015) Clinicopathological significance of ASC-amino acid transporter 2 (ASCT2) expression in pancreatic ductal carcinoma. Histopathology 66, 234-243
DOI
|
22 |
Brozovic A and Osmak M (2007) Activation of mitogenactivated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer Lett 251, 1-16
DOI
|
23 |
Kutuk O, Arisan ED, Tezil T, Shoshan MC and Basaga H (2009) Cisplatin overcomes Bcl-2-mediated resistance to apoptosis via preferential engagement of Bak: critical role of Noxa-mediated lipid peroxidation. Carcinogenesis 30, 1517-1527
DOI
|
24 |
Efeyan A and Serrano M (2007) p53: guardian of the genome and policeman of the oncogenes. Cell Cycle 6, 1006-1010
DOI
|
25 |
De Laurenzi V and Melino G (2000) Evolution of functions within the p53/p63/p73 family. Ann NY Acad Sci 926, 90-100
|
26 |
Santandreu FM, Valle A, Oliver J and Roca P (2011) Resveratrol potentiates the cytotoxic oxidative stress induced by chemotherapy in human colon cancer cells. Cell Physiol Biochem 28, 219-228
DOI
|
27 |
Llovet JM (2004) Treatment of hepatocellular carcinoma. Curr Treat Options Gastroenterol 7, 431-441
DOI
|
28 |
Murata S, Mine T, Sugihara F et al (2014) Interventional treatment for unresectable hepatocellular carcinoma. World J Gastroenterol 20, 13453-13465
DOI
|
29 |
Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet 359, 1734-1739
DOI
|
30 |
Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35, 1164-1171
DOI
|
31 |
Shaaban S, Negm A, Ibrahim EE et al (2014) Chemotherapeutic agent for the treatment of hepatocellular carcinoma: efficacy and mode of action. Oncol Rev 8, 25-35
|
32 |
Gupta SC, Kannappan R, Reuter S, Kim JH and Aqqarwal BB (2011) Chemosensitization of tumors by resveratrol. Ann NY Acad Sci 1215, 150-160
DOI
|
33 |
Sale S, Tunstall RG, Ruparelia KC, Potter GA, Steward WP and Gescher AJ (2005) Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc (Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells. Int J Cancer 115, 194-201
DOI
|
34 |
Newsholme E, Crabtree B and Ardawi M (1985) The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Biosci Rep 5, 393-400
DOI
|
35 |
Wellen KE, Lu C, Mancuso A et al (2010) The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev 24, 2784-2799
DOI
|
36 |
Kueck A, Opipari AW, Griffith KA et al (2007) Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol 107, 450-457
DOI
|